ArticleiScience2026
Brain age gap as biomarker linking cardiovascular diseases genetic susceptibility and causality.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular diseases (CVDs) remain a primary cause of global mortality, underscoring the need for biomarkers that capture systemic aging risks. T1-weighted magnetic resonance imaging (MRI) data from UK Biobank (UKB) participants were utilized to develop a three-dimensional vision transformer (3D-ViT) model for predicting brain age and computing BAG, an imaging-derived indicator of biological aging. Causal BAG-CVD relationships were assessed through bidirectional Mendelian randomization (MR). The results substantiated significant brain-heart interactions, revealing that acute myocardial infarction (AMI) and chronic ischemic heart disease (CIH) were associated with decelerated brain aging (OR = 0.783; OR = 0.847), while an elevated BAG correlated with a reduced risk of AMI and CIH (OR = 0.954; OR = 0.969). These findings highlight BAG as an integrative indicator combining neuroimaging and genetic profiles. The observed bidirectional causality offers a biological framework for defining intervention strategies targeting comorbid brain and cardiovascular health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.